Preclinical and Clinical Status of PSMA-Targeted Alpha Therapy for Metastatic Castration-Resistant Prostate Cancer

SIMPLE SUMMARY: Currently, there is no treatment that can cure patients with late stage metastatic prostate cancer. Prostate-specific membrane antigen is a type of protein overexpressed on the membrane surface of most prostate cancer cells. The preclinical and clinical experiences in the rapidly evo...

Descripción completa

Detalles Bibliográficos
Autores principales: Juzeniene, Asta, Stenberg, Vilde Yuli, Bruland, Øyvind Sverre, Larsen, Roy Hartvig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918517/
https://www.ncbi.nlm.nih.gov/pubmed/33668474
http://dx.doi.org/10.3390/cancers13040779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918517/
https://www.ncbi.nlm.nih.gov/pubmed/33668474
http://dx.doi.org/10.3390/cancers13040779

Ejemplares similares